182 related articles for article (PubMed ID: 3087281)
1. In vitro activity of BRL 36650, a new penicillin.
Van Landuyt HW; Lambert A; Boelaert J; Gordts B
Antimicrob Agents Chemother; 1986 Feb; 29(2):362-6. PubMed ID: 3087281
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.
Fuchs PC; Jones RN; Barry AL; Ayers LW; Gavan TL; Gerlach EH
Diagn Microbiol Infect Dis; 1986 Nov; 5(4):345-9. PubMed ID: 3536278
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
Hoogkamp-Korstanje JA; Meijer CA
Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
[TBL] [Abstract][Full Text] [Related]
4. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
Verbist L; Glupczynski Y
Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of cefepime against nosocomial isolates.
Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
Verbist L
J Antimicrob Chemother; 1986 Sep; 18(3):351-8. PubMed ID: 3095299
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin.
Basker MJ; Edmondson RA; Knott SJ; Ponsford RJ; Slocombe B; White SJ
Antimicrob Agents Chemother; 1984 Nov; 26(5):734-40. PubMed ID: 6440479
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.
Voutsinas D; Mavroudis T; Avlamis A; Giamarellou H
Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):917-9. PubMed ID: 2512141
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
12. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
Oie S; Sawa A; Kamiya A; Mizuno H
J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
[TBL] [Abstract][Full Text] [Related]
13. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
14. Activity of antibiotics against resistant Pseudomonas aeruginosa.
Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of 523 blood culture isolates to 33 antibiotics.
Ode B; Forsgren A; Walder M
Scand J Infect Dis; 1984; 16(1):61-71. PubMed ID: 6559413
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
Gerçeker AA; Gürler B
J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
20. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
Heym B; Lacroix O; Péan Y; Gertner J; Nicolas MH; Jarlier V
J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
